At the onset of adopting decentralised clinical trial (DCT) models, sponsors and sites prioritise the integration of electronic clinical outcome assessments (eCOAs) as essential tools.
The life sciences industry faces many challenges, driving a critical need for rapid digital transformation with data-driven decision-making as the backbone for change.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.